Skip to main content

Table 2 Baseline group characteristics and outcome measures at baseline and reassessment

From: Combining cognitive stimulation therapy and fall prevention exercise (CogEx) in older adults with mild to moderate dementia: a feasibility randomised controlled trial

  Baseline   Reassessment  
CST CogEx CST CogEx
Number of residents randomised 10 13 9 11
Mean age in years, (range) 83.6 (71-95) 87.5 (81-95)
Female, n (%) 8 (80) 9 (69)
Uses a walking device, n (%) 4 (40) 9 (69)
Medication, mean (SD) 5.2 (2.5) 6.8 (3.6)
MoCA, mean (SD) 18.0 (5.6) 16.0 (4.2) 18.3 (6.9) 14.6 (3.3)
GDS-15, mean (SD) 3.8 (3.4) 2.9 (2.8) 4.3 (5.1) 2.6 (2.0)
QoL: AD, mean (SD) 37.7 (5.8) 37.2 (6.4) 37.2 (5.7) 37.6 (4.8)
ADAS-Cog 11, mean (SD) 15.0 (10.4) 17.4 (5.9) 14.9 (9.5) 18.4 (5.5)
Brief BESTest, mean (SD) 8.5 (5.5) 9.0 (6.0) 10.3 (5.2) 8.2 (5.1)
SPPB
 Balance score, mean (SD) 2.4 (1.4) 2.4 (1.6) 3.0 (1.0) 2.3 (1.3)
 Gait score, mean (SD) 2.3 (1.4) 2.6 (1.2) 2.0 (1.0) 2.2 (1.3)
 Chair stand score, mean (SD) 0.8 (0.4) 1.3 (1.3) 1.2 (1.1) 0.9 (0.9)
 Total score, mean (SD) 5.5 (2.1) 6.3 (3.8) 6.2 (2.2) 5.4 (2.9)
  1. MoCA Montreal Cognitive Assessment (0–30, a higher score = better cognition); GDS-15 Geriatric Depression Scale—15 (0–15, A score of > 5 = likely to have depression); QoL AD quality of life: Alzheimer’s disease (13–52, a higher the score = better the quality of life); ADAS-Cog 11 Alzheimer’s Disease Assessment Scale—Cognitive 11 (0–70, a lower score = better cognition); Brief BESTest Brief Balance Evaluation Systems Test (0–30, a higher score = better balance performance); SPPB Short Form Physical Performance Battery (item score 0–4, total score 0–12, a higher score indicates better performance)